Combined ibrutinib and venetoclax for treatment of patients with ibrutinib‐resistant or double‐refractory chronic lymphocytic leukaemia
暂无分享,去创建一个
S. Slager | E. Braggio | N. Kay | Yucai Wang | K. Rabe | Eli Muchtar | T. Call | R. Parrondo | S. Parikh | S. Kenderian | J. Leis | W. Ding | S. Schwager | M. Shi | P. Hampel | A. Koehler | Ricardo D. Parrondo